Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1957 Dec 21;2(5059):1468–1471. doi: 10.1136/bmj.2.5059.1468

Medullary Aplasia in Chronic Myeloid Leukaemia during Busulphan Therapy

F G J Hayhoe, D'Almero Kok
PMCID: PMC1962898  PMID: 13489262

Full text

PDF
1468

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERNARD J., MATHE G., NAJEAN Y. Traitement de 50 leucémies myéloides chroniques par le 1-4 diméthane-sulfonyl-oxybutane. Sem Hop. 1955 Oct 6;31(59):3082–3087. [PubMed] [Google Scholar]
  2. BLACKBURN E. K., KING G. M., SWAN H. T. Myleran in treatment of chronic myeloid leukaemia. Br Med J. 1956 Apr 14;1(4971):835–837. doi: 10.1136/bmj.1.4971.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BOLLAG W. Myleran, ein neues Cytostaticum bei Leukämien. Schweiz Med Wochenschr. 1953 Sep 12;83(37):872–876. [PubMed] [Google Scholar]
  4. FROST J. W., JACKSON C. B., Jr Myleran in the treatment of chronic granulocytic leukemia. J Am Med Assoc. 1956 May 5;161(1):54–56. doi: 10.1001/jama.1956.62970010006015b. [DOI] [PubMed] [Google Scholar]
  5. GALTON D. A., TILL M. Myleran in chronic myeloid leukaemia. Lancet. 1955 Feb 26;268(6861):425–430. doi: 10.1016/s0140-6736(55)90212-9. [DOI] [PubMed] [Google Scholar]
  6. HAUT A., ALTMAN S. J., CARTWRIGHT G. E., WINTROBE M. M. The use of myleran in the treatment of chronic myelocytic leukemia. AMA Arch Intern Med. 1955 Oct;96(4):451–462. doi: 10.1001/archinte.1955.00250150025002. [DOI] [PubMed] [Google Scholar]
  7. HYMAN G. A., GELLHORN A. Myleran therapy in malignant neoplastic disease; use of 1,4-dimethanesulfonyloxbutane with emphasis on chronic granulocytic leukemia. J Am Med Assoc. 1956 Jun 30;161(9):844–849. doi: 10.1001/jama.1956.02970090070014. [DOI] [PubMed] [Google Scholar]
  8. KURRLE G. R. Myleran: a review of its action and a report on its use in chronic myeloid leuchaemia. Med J Aust. 1955 Apr 30;42(1 18):636–641. [PubMed] [Google Scholar]
  9. LOUIS J., LIMARZI L. R., BEST W. R. Treatment of chronic granulocytic leukemia with myleran. AMA Arch Intern Med. 1956 Mar;97(3):299–308. doi: 10.1001/archinte.1956.00250210045003. [DOI] [PubMed] [Google Scholar]
  10. PETRAKIS N. L., BIERMAN H. R., KELLY K. H., WHITE L. P., SHIMKIN M. B. The effect of 1,4-dimethanesulfonyloxybutane (GT-41 or myleran) upon leukemia. Cancer. 1954 Mar;7(2):383–390. doi: 10.1002/1097-0142(195403)7:2<383::aid-cncr2820070225>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  11. STORTI E., PEDERZINI A. Alcuni casi di leucosi mieloide acuta e cronica trattati con 1-4-dimetilsulfonossibutano. Prog Med (Napoli) 1955 Jul 15;11(13):390–397. [PubMed] [Google Scholar]
  12. WAGNER K. Klinische Erfahrungen mit Sulfabutin in der Leukämiebehandlung. Wien Med Wochenschr. 1954 Dec 11;104(50):1002–1004. [PubMed] [Google Scholar]
  13. WILKINSON J. F., HADDOW A., NABARRO J. D. Discussion on the chemotherapy of the reticuloses. Proc R Soc Med. 1953 Sep;46(9):685–700. doi: 10.1177/003591575304600901. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES